A one-stop-shop for tools and information sources supporting the ongoing efforts to defeat the Covid19 pandemic
The Coronavirus R&D Gateway is a resource for researchers, companies, policymakers and the interested public at large. The R&D Gateway has been created in cooperation with several partner organisations. It constitutes a one-stop-shop for a number of tools and information sources supporting the ongoing efforts to defeat the COVID-19 pandemic.
The research should determine how susceptible cystic fibrosis (CF) cells are to COVID-19, identify and evaluate responses to the virus in people with CF, and understand how commonly prescribed medications used in CF may alter responses to the virus. Letters of intent should be sent by 17 July.
No upcoming events
For partnership opportunities, contact [email protected]